Last year, Lilly struck a deal to acquire gene therapy company Verve Therapeutics for approximately $1 billion, with the potential value rising to $1.3 billion if milestones are achieved
Building these habits while on medication, when appetite suppression makes adherence easier, significantly improves success rates
Semaglutide weight loss injections are administered once a week, for as long as necessary to help the recipient achieve their weight loss goal
Its long-term safety profile is still being characterized in Phase 3 research
A total of 1407 randomized adults, with a mean baseline body weight of 113 kg, were randomized to once-weekly semaglutide 7.2 mg, semaglutide 2.4 mg, or placebo over 72 weeks, in conjunction with lifestyle intervention